plasma cell leukemia pcl section view illustration
|
||||||||||||||
|
|
|
|
||||||||||||
|
||||||||||||||
Stockphotos.ro (c) 2024. All stock photos are provided by Dreamstime and are copyrighted by their respective owners.
plasma cell leukemia pcl section view illustration |
||||||||||||||||||||||||||||||||||||||||
| navigate by keyword : plasma cell multiple myeloma non hodgkin lymphoma lymphoid tissues car tcr chimeric antigen receptor immunotherapy acute lymphoblastic leukaemia myeloid amyloid anemia antibody therapy basophil biological blood cancer bone marrow chemotherapy chronic lymphocytic myelogenous deformity dna electrophoresis erythrocytes hematology histology hypergranular promyelocytic lymphocyte malignant growths mds metastasis monocyte mpns neutrophil oncology radiation stem treatment tumor white cells |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| Plasma cell leukemia (PCL) is a plasma cell dyscrasia, i.e. a disease involving the malignant degeneration of a subtype of white blood cells called plasma cells. It is the terminal stage and most aggressive form of these dyscrasias, constituting 2% to 4% of all cases of plasma cell malignancies. |
||||||||||||||||||||||||||||||||||||||||
|
Stockphotos.ro (c) 2024. All stock photos are provided by Dreamstime and are copyrighted by their respective owners. |
||||||||||||||||||||||||||||||||||||||||